Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Quanlu Dabu Wan is a traditional Chinese medicine (TCM) product manufactured by Liaoning Jindan Pharmaceutical. It is a complex multi-ingredient formulation traditionally used to tonify the kidneys, replenish essence, and nourish qi and blood. The preparation typically includes whole deer (or deer-derived components) as the primary ingredient, combined with numerous other medicinal herbs such as Ginseng, Astragalus, and Rehmannia. It is indicated for patients suffering from deficiencies in both qi and blood, as well as kidney yang deficiency, which manifest as symptoms like physical exhaustion, dizziness, tinnitus, lower back pain, and cold extremities. As a TCM product, it functions through a holistic, multi-target approach to restore physiological balance and strengthen the body's constitution. It is an approved marketed product in China.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on quanlu dabu wan.